nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisuride—CYP2D6—Hydroxyurea—psoriasis	0.0828	0.162	CbGbCtD
Lisuride—CYP3A4—Calcitriol—psoriasis	0.0619	0.121	CbGbCtD
Lisuride—CYP2D6—Cholecalciferol—psoriasis	0.0502	0.0981	CbGbCtD
Lisuride—CYP3A4—Methoxsalen—psoriasis	0.0482	0.0942	CbGbCtD
Lisuride—CYP2D6—Cyclosporine—psoriasis	0.033	0.0645	CbGbCtD
Lisuride—CYP3A4—Cholecalciferol—psoriasis	0.0319	0.0624	CbGbCtD
Lisuride—CYP3A4—Mycophenolate mofetil—psoriasis	0.0277	0.0541	CbGbCtD
Lisuride—CYP3A4—Triamcinolone—psoriasis	0.0277	0.0541	CbGbCtD
Lisuride—CYP3A4—Betamethasone—psoriasis	0.0237	0.0464	CbGbCtD
Lisuride—CYP3A4—Prednisolone—psoriasis	0.0234	0.0458	CbGbCtD
Lisuride—CYP3A4—Hydrocortisone—psoriasis	0.0222	0.0434	CbGbCtD
Lisuride—CYP3A4—Prednisone—psoriasis	0.0221	0.0433	CbGbCtD
Lisuride—CYP2D6—Dexamethasone—psoriasis	0.0217	0.0425	CbGbCtD
Lisuride—CYP3A4—Cyclosporine—psoriasis	0.021	0.041	CbGbCtD
Lisuride—CYP3A4—Dexamethasone—psoriasis	0.0138	0.027	CbGbCtD
Lisuride—Weight increased—Mycophenolate mofetil—psoriasis	0.00133	0.00323	CcSEcCtD
Lisuride—Weight decreased—Mycophenolate mofetil—psoriasis	0.00133	0.00321	CcSEcCtD
Lisuride—Feeling abnormal—Acitretin—psoriasis	0.00132	0.00321	CcSEcCtD
Lisuride—Mental disorder—Mycophenolic acid—psoriasis	0.0013	0.00316	CcSEcCtD
Lisuride—Asthenia—Calcitriol—psoriasis	0.0013	0.00314	CcSEcCtD
Lisuride—Malnutrition—Mycophenolic acid—psoriasis	0.00129	0.00314	CcSEcCtD
Lisuride—Headache—Methoxsalen—psoriasis	0.00127	0.00307	CcSEcCtD
Lisuride—Sweating—Mycophenolate mofetil—psoriasis	0.00125	0.00304	CcSEcCtD
Lisuride—Infection—Hydroxyurea—psoriasis	0.00125	0.00304	CcSEcCtD
Lisuride—Weight increased—Prednisolone—psoriasis	0.00124	0.00301	CcSEcCtD
Lisuride—Nervous system disorder—Hydroxyurea—psoriasis	0.00124	0.003	CcSEcCtD
Lisuride—Weight increased—Hydrocortisone—psoriasis	0.00122	0.00294	CcSEcCtD
Lisuride—Weight decreased—Hydrocortisone—psoriasis	0.00121	0.00293	CcSEcCtD
Lisuride—Anorexia—Hydroxyurea—psoriasis	0.0012	0.00291	CcSEcCtD
Lisuride—Hallucination—Mycophenolate mofetil—psoriasis	0.00117	0.00283	CcSEcCtD
Lisuride—Vertigo—Mycophenolic acid—psoriasis	0.00116	0.00282	CcSEcCtD
Lisuride—Syncope—Mycophenolic acid—psoriasis	0.00116	0.00281	CcSEcCtD
Lisuride—Oedema peripheral—Mycophenolate mofetil—psoriasis	0.00116	0.0028	CcSEcCtD
Lisuride—Asthenia—Acitretin—psoriasis	0.00115	0.00279	CcSEcCtD
Lisuride—Vomiting—Calcitriol—psoriasis	0.00115	0.00278	CcSEcCtD
Lisuride—Weight increased—Triamcinolone—psoriasis	0.00114	0.00277	CcSEcCtD
Lisuride—Palpitations—Mycophenolic acid—psoriasis	0.00114	0.00277	CcSEcCtD
Lisuride—Headache—Calcitriol—psoriasis	0.00113	0.00274	CcSEcCtD
Lisuride—Cough—Mycophenolic acid—psoriasis	0.00113	0.00274	CcSEcCtD
Lisuride—Dyspnoea—Hydroxyurea—psoriasis	0.00112	0.00272	CcSEcCtD
Lisuride—Somnolence—Hydroxyurea—psoriasis	0.00112	0.00272	CcSEcCtD
Lisuride—Anxiety—Mycophenolic acid—psoriasis	0.0011	0.00266	CcSEcCtD
Lisuride—Decreased appetite—Hydroxyurea—psoriasis	0.0011	0.00266	CcSEcCtD
Lisuride—Angiopathy—Cyclosporine—psoriasis	0.00109	0.00264	CcSEcCtD
Lisuride—Cardiac disorder—Mycophenolate mofetil—psoriasis	0.00109	0.00264	CcSEcCtD
Lisuride—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.00109	0.00264	CcSEcCtD
Lisuride—Fatigue—Hydroxyurea—psoriasis	0.00109	0.00263	CcSEcCtD
Lisuride—Mediastinal disorder—Cyclosporine—psoriasis	0.00108	0.00263	CcSEcCtD
Lisuride—Constipation—Hydroxyurea—psoriasis	0.00108	0.00261	CcSEcCtD
Lisuride—Dry mouth—Mycophenolic acid—psoriasis	0.00108	0.00261	CcSEcCtD
Lisuride—Confusional state—Mycophenolic acid—psoriasis	0.00107	0.00258	CcSEcCtD
Lisuride—Angiopathy—Mycophenolate mofetil—psoriasis	0.00106	0.00258	CcSEcCtD
Lisuride—Hallucination—Hydrocortisone—psoriasis	0.00106	0.00258	CcSEcCtD
Lisuride—Dizziness—Acitretin—psoriasis	0.00106	0.00257	CcSEcCtD
Lisuride—Dizziness—Fluocinolone Acetonide—psoriasis	0.00106	0.00257	CcSEcCtD
Lisuride—Mediastinal disorder—Mycophenolate mofetil—psoriasis	0.00106	0.00256	CcSEcCtD
Lisuride—Mental disorder—Cyclosporine—psoriasis	0.00105	0.00255	CcSEcCtD
Lisuride—Infection—Mycophenolic acid—psoriasis	0.00105	0.00254	CcSEcCtD
Lisuride—Malnutrition—Cyclosporine—psoriasis	0.00105	0.00254	CcSEcCtD
Lisuride—Feeling abnormal—Hydroxyurea—psoriasis	0.00104	0.00252	CcSEcCtD
Lisuride—Weight increased—Betamethasone—psoriasis	0.00104	0.00252	CcSEcCtD
Lisuride—Weight increased—Dexamethasone—psoriasis	0.00104	0.00252	CcSEcCtD
Lisuride—Nervous system disorder—Mycophenolic acid—psoriasis	0.00104	0.00251	CcSEcCtD
Lisuride—Weight decreased—Dexamethasone—psoriasis	0.00103	0.0025	CcSEcCtD
Lisuride—Weight decreased—Betamethasone—psoriasis	0.00103	0.0025	CcSEcCtD
Lisuride—Tachycardia—Mycophenolic acid—psoriasis	0.00103	0.0025	CcSEcCtD
Lisuride—Mental disorder—Mycophenolate mofetil—psoriasis	0.00103	0.00249	CcSEcCtD
Lisuride—Malnutrition—Mycophenolate mofetil—psoriasis	0.00102	0.00247	CcSEcCtD
Lisuride—Vomiting—Acitretin—psoriasis	0.00102	0.00247	CcSEcCtD
Lisuride—Hyperhidrosis—Mycophenolic acid—psoriasis	0.00102	0.00247	CcSEcCtD
Lisuride—Vomiting—Fluocinolone Acetonide—psoriasis	0.00102	0.00247	CcSEcCtD
Lisuride—Anorexia—Mycophenolic acid—psoriasis	0.00101	0.00244	CcSEcCtD
Lisuride—Headache—Acitretin—psoriasis	0.00101	0.00244	CcSEcCtD
Lisuride—Headache—Fluocinolone Acetonide—psoriasis	0.001	0.00243	CcSEcCtD
Lisuride—Immune system disorder—Hydrocortisone—psoriasis	0.000966	0.00234	CcSEcCtD
Lisuride—Insomnia—Mycophenolic acid—psoriasis	0.000955	0.00231	CcSEcCtD
Lisuride—Dyspnoea—Mycophenolic acid—psoriasis	0.000942	0.00228	CcSEcCtD
Lisuride—Vertigo—Cyclosporine—psoriasis	0.000941	0.00228	CcSEcCtD
Lisuride—Somnolence—Mycophenolic acid—psoriasis	0.000939	0.00227	CcSEcCtD
Lisuride—Mental disorder—Hydrocortisone—psoriasis	0.000937	0.00227	CcSEcCtD
Lisuride—Malnutrition—Hydrocortisone—psoriasis	0.000931	0.00225	CcSEcCtD
Lisuride—Decreased appetite—Mycophenolic acid—psoriasis	0.000918	0.00222	CcSEcCtD
Lisuride—Vertigo—Mycophenolate mofetil—psoriasis	0.000918	0.00222	CcSEcCtD
Lisuride—Syncope—Mycophenolate mofetil—psoriasis	0.000916	0.00222	CcSEcCtD
Lisuride—Cough—Cyclosporine—psoriasis	0.000914	0.00221	CcSEcCtD
Lisuride—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000912	0.00221	CcSEcCtD
Lisuride—Fatigue—Mycophenolic acid—psoriasis	0.000911	0.00221	CcSEcCtD
Lisuride—Hallucination—Dexamethasone—psoriasis	0.000909	0.0022	CcSEcCtD
Lisuride—Hallucination—Betamethasone—psoriasis	0.000909	0.0022	CcSEcCtD
Lisuride—Asthenia—Hydroxyurea—psoriasis	0.000905	0.00219	CcSEcCtD
Lisuride—Weight increased—Prednisone—psoriasis	0.000904	0.00219	CcSEcCtD
Lisuride—Constipation—Mycophenolic acid—psoriasis	0.000903	0.00219	CcSEcCtD
Lisuride—Palpitations—Mycophenolate mofetil—psoriasis	0.000903	0.00219	CcSEcCtD
Lisuride—Weight decreased—Prednisone—psoriasis	0.000899	0.00218	CcSEcCtD
Lisuride—Cough—Mycophenolate mofetil—psoriasis	0.000891	0.00216	CcSEcCtD
Lisuride—Anxiety—Cyclosporine—psoriasis	0.000888	0.00215	CcSEcCtD
Lisuride—Dry mouth—Cyclosporine—psoriasis	0.000872	0.00211	CcSEcCtD
Lisuride—Feeling abnormal—Mycophenolic acid—psoriasis	0.00087	0.00211	CcSEcCtD
Lisuride—Anxiety—Mycophenolate mofetil—psoriasis	0.000867	0.0021	CcSEcCtD
Lisuride—Confusional state—Cyclosporine—psoriasis	0.000862	0.00209	CcSEcCtD
Lisuride—Vertigo—Prednisolone—psoriasis	0.000856	0.00207	CcSEcCtD
Lisuride—Syncope—Prednisolone—psoriasis	0.000854	0.00207	CcSEcCtD
Lisuride—Dry mouth—Mycophenolate mofetil—psoriasis	0.00085	0.00206	CcSEcCtD
Lisuride—Infection—Cyclosporine—psoriasis	0.000849	0.00206	CcSEcCtD
Lisuride—Confusional state—Mycophenolate mofetil—psoriasis	0.000841	0.00204	CcSEcCtD
Lisuride—Nervous system disorder—Cyclosporine—psoriasis	0.000838	0.00203	CcSEcCtD
Lisuride—Vertigo—Hydrocortisone—psoriasis	0.000836	0.00203	CcSEcCtD
Lisuride—Syncope—Hydrocortisone—psoriasis	0.000834	0.00202	CcSEcCtD
Lisuride—Dizziness—Hydroxyurea—psoriasis	0.000834	0.00202	CcSEcCtD
Lisuride—Angiopathy—Betamethasone—psoriasis	0.000829	0.00201	CcSEcCtD
Lisuride—Angiopathy—Dexamethasone—psoriasis	0.000829	0.00201	CcSEcCtD
Lisuride—Infection—Mycophenolate mofetil—psoriasis	0.000828	0.00201	CcSEcCtD
Lisuride—Hyperhidrosis—Cyclosporine—psoriasis	0.000826	0.002	CcSEcCtD
Lisuride—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000818	0.00198	CcSEcCtD
Lisuride—Anorexia—Cyclosporine—psoriasis	0.000815	0.00197	CcSEcCtD
Lisuride—Tachycardia—Mycophenolate mofetil—psoriasis	0.000814	0.00197	CcSEcCtD
Lisuride—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.000806	0.00195	CcSEcCtD
Lisuride—Vomiting—Hydroxyurea—psoriasis	0.000802	0.00194	CcSEcCtD
Lisuride—Abdominal discomfort—Methotrexate—psoriasis	0.000796	0.00193	CcSEcCtD
Lisuride—Anorexia—Mycophenolate mofetil—psoriasis	0.000795	0.00192	CcSEcCtD
Lisuride—Hallucination—Prednisone—psoriasis	0.000791	0.00192	CcSEcCtD
Lisuride—Headache—Hydroxyurea—psoriasis	0.00079	0.00191	CcSEcCtD
Lisuride—Anxiety—Hydrocortisone—psoriasis	0.000789	0.00191	CcSEcCtD
Lisuride—Vertigo—Triamcinolone—psoriasis	0.000787	0.00191	CcSEcCtD
Lisuride—Syncope—Triamcinolone—psoriasis	0.000786	0.0019	CcSEcCtD
Lisuride—Insomnia—Cyclosporine—psoriasis	0.000773	0.00187	CcSEcCtD
Lisuride—Cough—Triamcinolone—psoriasis	0.000765	0.00185	CcSEcCtD
Lisuride—Dyspnoea—Cyclosporine—psoriasis	0.000762	0.00185	CcSEcCtD
Lisuride—Somnolence—Cyclosporine—psoriasis	0.00076	0.00184	CcSEcCtD
Lisuride—Tachycardia—Prednisolone—psoriasis	0.000759	0.00184	CcSEcCtD
Lisuride—Asthenia—Mycophenolic acid—psoriasis	0.000758	0.00184	CcSEcCtD
Lisuride—Infection—Hydrocortisone—psoriasis	0.000754	0.00183	CcSEcCtD
Lisuride—Insomnia—Mycophenolate mofetil—psoriasis	0.000754	0.00183	CcSEcCtD
Lisuride—Hyperhidrosis—Prednisolone—psoriasis	0.000752	0.00182	CcSEcCtD
Lisuride—Nervous system disorder—Hydrocortisone—psoriasis	0.000745	0.0018	CcSEcCtD
Lisuride—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000743	0.0018	CcSEcCtD
Lisuride—Decreased appetite—Cyclosporine—psoriasis	0.000743	0.0018	CcSEcCtD
Lisuride—Tachycardia—Hydrocortisone—psoriasis	0.000741	0.0018	CcSEcCtD
Lisuride—Somnolence—Mycophenolate mofetil—psoriasis	0.000741	0.0018	CcSEcCtD
Lisuride—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000738	0.00179	CcSEcCtD
Lisuride—Fatigue—Cyclosporine—psoriasis	0.000737	0.00178	CcSEcCtD
Lisuride—Hyperhidrosis—Hydrocortisone—psoriasis	0.000734	0.00178	CcSEcCtD
Lisuride—Constipation—Cyclosporine—psoriasis	0.000731	0.00177	CcSEcCtD
Lisuride—Dry mouth—Triamcinolone—psoriasis	0.00073	0.00177	CcSEcCtD
Lisuride—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000725	0.00176	CcSEcCtD
Lisuride—Anorexia—Hydrocortisone—psoriasis	0.000724	0.00175	CcSEcCtD
Lisuride—Angiopathy—Prednisone—psoriasis	0.000722	0.00175	CcSEcCtD
Lisuride—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.00072	0.00174	CcSEcCtD
Lisuride—Immune system disorder—Prednisone—psoriasis	0.000718	0.00174	CcSEcCtD
Lisuride—Vertigo—Dexamethasone—psoriasis	0.000714	0.00173	CcSEcCtD
Lisuride—Vertigo—Betamethasone—psoriasis	0.000714	0.00173	CcSEcCtD
Lisuride—Syncope—Dexamethasone—psoriasis	0.000713	0.00173	CcSEcCtD
Lisuride—Syncope—Betamethasone—psoriasis	0.000713	0.00173	CcSEcCtD
Lisuride—Constipation—Mycophenolate mofetil—psoriasis	0.000713	0.00173	CcSEcCtD
Lisuride—Infection—Triamcinolone—psoriasis	0.00071	0.00172	CcSEcCtD
Lisuride—Sweating—Methotrexate—psoriasis	0.00071	0.00172	CcSEcCtD
Lisuride—Feeling abnormal—Cyclosporine—psoriasis	0.000704	0.00171	CcSEcCtD
Lisuride—Insomnia—Prednisolone—psoriasis	0.000703	0.0017	CcSEcCtD
Lisuride—Dizziness—Mycophenolic acid—psoriasis	0.000699	0.00169	CcSEcCtD
Lisuride—Tachycardia—Triamcinolone—psoriasis	0.000698	0.00169	CcSEcCtD
Lisuride—Mental disorder—Prednisone—psoriasis	0.000697	0.00169	CcSEcCtD
Lisuride—Malnutrition—Prednisone—psoriasis	0.000692	0.00168	CcSEcCtD
Lisuride—Hyperhidrosis—Triamcinolone—psoriasis	0.000691	0.00167	CcSEcCtD
Lisuride—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000687	0.00166	CcSEcCtD
Lisuride—Insomnia—Hydrocortisone—psoriasis	0.000687	0.00166	CcSEcCtD
Lisuride—Anxiety—Dexamethasone—psoriasis	0.000675	0.00163	CcSEcCtD
Lisuride—Anxiety—Betamethasone—psoriasis	0.000675	0.00163	CcSEcCtD
Lisuride—Vomiting—Mycophenolic acid—psoriasis	0.000672	0.00163	CcSEcCtD
Lisuride—Headache—Mycophenolic acid—psoriasis	0.000662	0.0016	CcSEcCtD
Lisuride—Decreased appetite—Hydrocortisone—psoriasis	0.00066	0.0016	CcSEcCtD
Lisuride—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000656	0.00159	CcSEcCtD
Lisuride—Fatigue—Hydrocortisone—psoriasis	0.000655	0.00159	CcSEcCtD
Lisuride—Insomnia—Triamcinolone—psoriasis	0.000647	0.00157	CcSEcCtD
Lisuride—Infection—Dexamethasone—psoriasis	0.000645	0.00156	CcSEcCtD
Lisuride—Infection—Betamethasone—psoriasis	0.000645	0.00156	CcSEcCtD
Lisuride—Feeling abnormal—Prednisolone—psoriasis	0.000641	0.00155	CcSEcCtD
Lisuride—Dyspnoea—Triamcinolone—psoriasis	0.000638	0.00154	CcSEcCtD
Lisuride—Nervous system disorder—Betamethasone—psoriasis	0.000636	0.00154	CcSEcCtD
Lisuride—Nervous system disorder—Dexamethasone—psoriasis	0.000636	0.00154	CcSEcCtD
Lisuride—Tachycardia—Dexamethasone—psoriasis	0.000633	0.00153	CcSEcCtD
Lisuride—Tachycardia—Betamethasone—psoriasis	0.000633	0.00153	CcSEcCtD
Lisuride—Hyperhidrosis—Dexamethasone—psoriasis	0.000627	0.00152	CcSEcCtD
Lisuride—Hyperhidrosis—Betamethasone—psoriasis	0.000627	0.00152	CcSEcCtD
Lisuride—Feeling abnormal—Hydrocortisone—psoriasis	0.000626	0.00152	CcSEcCtD
Lisuride—Vertigo—Prednisone—psoriasis	0.000622	0.00151	CcSEcCtD
Lisuride—Syncope—Prednisone—psoriasis	0.000621	0.0015	CcSEcCtD
Lisuride—Anorexia—Dexamethasone—psoriasis	0.000618	0.0015	CcSEcCtD
Lisuride—Anorexia—Betamethasone—psoriasis	0.000618	0.0015	CcSEcCtD
Lisuride—Cardiac disorder—Methotrexate—psoriasis	0.000617	0.00149	CcSEcCtD
Lisuride—Fatigue—Triamcinolone—psoriasis	0.000617	0.00149	CcSEcCtD
Lisuride—Asthenia—Cyclosporine—psoriasis	0.000613	0.00149	CcSEcCtD
Lisuride—Angiopathy—Methotrexate—psoriasis	0.000603	0.00146	CcSEcCtD
Lisuride—Immune system disorder—Methotrexate—psoriasis	0.0006	0.00145	CcSEcCtD
Lisuride—Mediastinal disorder—Methotrexate—psoriasis	0.000599	0.00145	CcSEcCtD
Lisuride—Asthenia—Mycophenolate mofetil—psoriasis	0.000598	0.00145	CcSEcCtD
Lisuride—Feeling abnormal—Triamcinolone—psoriasis	0.000589	0.00143	CcSEcCtD
Lisuride—Anxiety—Prednisone—psoriasis	0.000587	0.00142	CcSEcCtD
Lisuride—Insomnia—Dexamethasone—psoriasis	0.000587	0.00142	CcSEcCtD
Lisuride—Insomnia—Betamethasone—psoriasis	0.000587	0.00142	CcSEcCtD
Lisuride—Mental disorder—Methotrexate—psoriasis	0.000582	0.00141	CcSEcCtD
Lisuride—Malnutrition—Methotrexate—psoriasis	0.000579	0.0014	CcSEcCtD
Lisuride—Dizziness—Cyclosporine—psoriasis	0.000565	0.00137	CcSEcCtD
Lisuride—Decreased appetite—Dexamethasone—psoriasis	0.000564	0.00137	CcSEcCtD
Lisuride—Decreased appetite—Betamethasone—psoriasis	0.000564	0.00137	CcSEcCtD
Lisuride—Infection—Prednisone—psoriasis	0.000561	0.00136	CcSEcCtD
Lisuride—Gastrointestinal disorder—Betamethasone—psoriasis	0.00056	0.00136	CcSEcCtD
Lisuride—Gastrointestinal disorder—Dexamethasone—psoriasis	0.00056	0.00136	CcSEcCtD
Lisuride—Fatigue—Betamethasone—psoriasis	0.000559	0.00136	CcSEcCtD
Lisuride—Fatigue—Dexamethasone—psoriasis	0.000559	0.00136	CcSEcCtD
Lisuride—Nervous system disorder—Prednisone—psoriasis	0.000554	0.00134	CcSEcCtD
Lisuride—Tachycardia—Prednisone—psoriasis	0.000551	0.00134	CcSEcCtD
Lisuride—Dizziness—Mycophenolate mofetil—psoriasis	0.000551	0.00134	CcSEcCtD
Lisuride—Hyperhidrosis—Prednisone—psoriasis	0.000546	0.00132	CcSEcCtD
Lisuride—Asthenia—Hydrocortisone—psoriasis	0.000545	0.00132	CcSEcCtD
Lisuride—Vomiting—Cyclosporine—psoriasis	0.000543	0.00132	CcSEcCtD
Lisuride—Anorexia—Prednisone—psoriasis	0.000539	0.0013	CcSEcCtD
Lisuride—Headache—Cyclosporine—psoriasis	0.000535	0.0013	CcSEcCtD
Lisuride—Feeling abnormal—Dexamethasone—psoriasis	0.000535	0.0013	CcSEcCtD
Lisuride—Feeling abnormal—Betamethasone—psoriasis	0.000535	0.0013	CcSEcCtD
Lisuride—Vomiting—Mycophenolate mofetil—psoriasis	0.00053	0.00128	CcSEcCtD
Lisuride—Headache—Mycophenolate mofetil—psoriasis	0.000522	0.00127	CcSEcCtD
Lisuride—Vertigo—Methotrexate—psoriasis	0.00052	0.00126	CcSEcCtD
Lisuride—Dizziness—Prednisolone—psoriasis	0.000514	0.00125	CcSEcCtD
Lisuride—Asthenia—Triamcinolone—psoriasis	0.000513	0.00124	CcSEcCtD
Lisuride—Insomnia—Prednisone—psoriasis	0.000511	0.00124	CcSEcCtD
Lisuride—Cough—Methotrexate—psoriasis	0.000505	0.00122	CcSEcCtD
Lisuride—Dizziness—Hydrocortisone—psoriasis	0.000502	0.00122	CcSEcCtD
Lisuride—Decreased appetite—Prednisone—psoriasis	0.000491	0.00119	CcSEcCtD
Lisuride—Fatigue—Prednisone—psoriasis	0.000487	0.00118	CcSEcCtD
Lisuride—Headache—Prednisolone—psoriasis	0.000487	0.00118	CcSEcCtD
Lisuride—Constipation—Prednisone—psoriasis	0.000483	0.00117	CcSEcCtD
Lisuride—Vomiting—Hydrocortisone—psoriasis	0.000483	0.00117	CcSEcCtD
Lisuride—Confusional state—Methotrexate—psoriasis	0.000476	0.00115	CcSEcCtD
Lisuride—Headache—Hydrocortisone—psoriasis	0.000476	0.00115	CcSEcCtD
Lisuride—Dizziness—Triamcinolone—psoriasis	0.000473	0.00115	CcSEcCtD
Lisuride—Infection—Methotrexate—psoriasis	0.000469	0.00114	CcSEcCtD
Lisuride—Feeling abnormal—Prednisone—psoriasis	0.000466	0.00113	CcSEcCtD
Lisuride—Asthenia—Betamethasone—psoriasis	0.000466	0.00113	CcSEcCtD
Lisuride—Asthenia—Dexamethasone—psoriasis	0.000466	0.00113	CcSEcCtD
Lisuride—Nervous system disorder—Methotrexate—psoriasis	0.000463	0.00112	CcSEcCtD
Lisuride—Hyperhidrosis—Methotrexate—psoriasis	0.000457	0.00111	CcSEcCtD
Lisuride—Vomiting—Triamcinolone—psoriasis	0.000455	0.0011	CcSEcCtD
Lisuride—Anorexia—Methotrexate—psoriasis	0.00045	0.00109	CcSEcCtD
Lisuride—Headache—Triamcinolone—psoriasis	0.000448	0.00109	CcSEcCtD
Lisuride—Dizziness—Dexamethasone—psoriasis	0.000429	0.00104	CcSEcCtD
Lisuride—Dizziness—Betamethasone—psoriasis	0.000429	0.00104	CcSEcCtD
Lisuride—Insomnia—Methotrexate—psoriasis	0.000427	0.00103	CcSEcCtD
Lisuride—Dyspnoea—Methotrexate—psoriasis	0.000421	0.00102	CcSEcCtD
Lisuride—Somnolence—Methotrexate—psoriasis	0.00042	0.00102	CcSEcCtD
Lisuride—Vomiting—Betamethasone—psoriasis	0.000413	0.000999	CcSEcCtD
Lisuride—Vomiting—Dexamethasone—psoriasis	0.000413	0.000999	CcSEcCtD
Lisuride—Decreased appetite—Methotrexate—psoriasis	0.000411	0.000994	CcSEcCtD
Lisuride—Gastrointestinal disorder—Methotrexate—psoriasis	0.000408	0.000988	CcSEcCtD
Lisuride—Fatigue—Methotrexate—psoriasis	0.000407	0.000986	CcSEcCtD
Lisuride—Headache—Betamethasone—psoriasis	0.000406	0.000985	CcSEcCtD
Lisuride—Headache—Dexamethasone—psoriasis	0.000406	0.000985	CcSEcCtD
Lisuride—Asthenia—Prednisone—psoriasis	0.000405	0.000982	CcSEcCtD
Lisuride—Feeling abnormal—Methotrexate—psoriasis	0.000389	0.000943	CcSEcCtD
Lisuride—Dizziness—Prednisone—psoriasis	0.000374	0.000905	CcSEcCtD
Lisuride—Vomiting—Prednisone—psoriasis	0.000359	0.00087	CcSEcCtD
Lisuride—Headache—Prednisone—psoriasis	0.000354	0.000858	CcSEcCtD
Lisuride—Asthenia—Methotrexate—psoriasis	0.000339	0.000821	CcSEcCtD
Lisuride—Dizziness—Methotrexate—psoriasis	0.000312	0.000756	CcSEcCtD
Lisuride—Vomiting—Methotrexate—psoriasis	0.0003	0.000727	CcSEcCtD
Lisuride—Headache—Methotrexate—psoriasis	0.000296	0.000717	CcSEcCtD
Lisuride—ADRA2B—Signaling by GPCR—TYK2—psoriasis	2.62e-05	0.000345	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—TYK2—psoriasis	2.62e-05	0.000344	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—APOE—psoriasis	2.57e-05	0.000338	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—LEP—psoriasis	2.57e-05	0.000338	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—SOCS1—psoriasis	2.57e-05	0.000338	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—CXCL8—psoriasis	2.56e-05	0.000337	CbGpPWpGaD
Lisuride—ADRB1—GPCR downstream signaling—CXCL8—psoriasis	2.54e-05	0.000333	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—TYK2—psoriasis	2.53e-05	0.000333	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—APOE—psoriasis	2.53e-05	0.000333	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—LEP—psoriasis	2.53e-05	0.000333	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—CXCL8—psoriasis	2.53e-05	0.000332	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—CXCL8—psoriasis	2.53e-05	0.000332	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—SOCS1—psoriasis	2.53e-05	0.000332	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—TYK2—psoriasis	2.52e-05	0.000331	CbGpPWpGaD
Lisuride—ADRA2B—GPCR downstream signaling—CXCL8—psoriasis	2.51e-05	0.00033	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—CARM1—psoriasis	2.51e-05	0.00033	CbGpPWpGaD
Lisuride—ADRA2A—Hemostasis—VEGFA—psoriasis	2.45e-05	0.000322	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—TYK2—psoriasis	2.45e-05	0.000322	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—NFKBIA—psoriasis	2.45e-05	0.000322	CbGpPWpGaD
Lisuride—ADRA2B—Hemostasis—TP53—psoriasis	2.44e-05	0.000321	CbGpPWpGaD
Lisuride—HTR1A—GPCR downstream signaling—CXCL8—psoriasis	2.43e-05	0.000319	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—APOE—psoriasis	2.41e-05	0.000318	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—LEP—psoriasis	2.41e-05	0.000318	CbGpPWpGaD
Lisuride—HTR2C—GPCR downstream signaling—CXCL8—psoriasis	2.41e-05	0.000317	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—TYK2—psoriasis	2.41e-05	0.000317	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—NFKBIA—psoriasis	2.4e-05	0.000315	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—CAT—psoriasis	2.37e-05	0.000311	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—NFKBIA—psoriasis	2.36e-05	0.00031	CbGpPWpGaD
Lisuride—ADRA2C—GPCR downstream signaling—CXCL8—psoriasis	2.35e-05	0.000309	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—SOCS1—psoriasis	2.33e-05	0.000306	CbGpPWpGaD
Lisuride—ADRA1B—GPCR downstream signaling—CXCL8—psoriasis	2.31e-05	0.000304	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—CXCL8—psoriasis	2.3e-05	0.000303	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—SOCS1—psoriasis	2.29e-05	0.000301	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—CXCL8—psoriasis	2.28e-05	0.0003	CbGpPWpGaD
Lisuride—ADRA2C—Hemostasis—TP53—psoriasis	2.28e-05	0.0003	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—CXCL8—psoriasis	2.28e-05	0.000299	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—LEP—psoriasis	2.28e-05	0.000299	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—APOE—psoriasis	2.28e-05	0.000299	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—APOE—psoriasis	2.27e-05	0.000298	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—NFKBIA—psoriasis	2.25e-05	0.000296	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—LEP—psoriasis	2.25e-05	0.000295	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—APOE—psoriasis	2.25e-05	0.000295	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—LEP—psoriasis	2.25e-05	0.000295	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—APOE—psoriasis	2.25e-05	0.000295	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—TYK2—psoriasis	2.22e-05	0.000292	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—CXCL8—psoriasis	2.2e-05	0.00029	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—CXCL8—psoriasis	2.19e-05	0.000288	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—TYK2—psoriasis	2.19e-05	0.000287	CbGpPWpGaD
Lisuride—DRD5—Signaling by GPCR—IL6—psoriasis	2.17e-05	0.000285	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—CXCL8—psoriasis	2.13e-05	0.00028	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—CXCL8—psoriasis	2.13e-05	0.00028	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—NFKBIA—psoriasis	2.12e-05	0.000279	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—JUN—psoriasis	2.12e-05	0.000278	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—CXCL8—psoriasis	2.1e-05	0.000276	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—CXCL8—psoriasis	2.1e-05	0.000276	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—NFKBIA—psoriasis	2.09e-05	0.000275	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—NFKBIA—psoriasis	2.09e-05	0.000275	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—SOCS1—psoriasis	2.09e-05	0.000274	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—LEP—psoriasis	2.05e-05	0.000269	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—APOE—psoriasis	2.05e-05	0.000269	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—NFKB1—psoriasis	2.04e-05	0.000268	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—LEP—psoriasis	2.03e-05	0.000267	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—APOE—psoriasis	2.03e-05	0.000267	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—TYK2—psoriasis	2e-05	0.000263	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—TYK2—psoriasis	1.99e-05	0.000261	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—PPARG—psoriasis	1.97e-05	0.00026	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—TYK2—psoriasis	1.96e-05	0.000258	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—LEP—psoriasis	1.96e-05	0.000257	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—APOE—psoriasis	1.96e-05	0.000257	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—LEP—psoriasis	1.95e-05	0.000256	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—APOE—psoriasis	1.95e-05	0.000256	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—CXCL8—psoriasis	1.93e-05	0.000254	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—TYK2—psoriasis	1.93e-05	0.000254	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—NFKBIA—psoriasis	1.91e-05	0.000251	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—CXCL8—psoriasis	1.91e-05	0.000251	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—CXCL8—psoriasis	1.9e-05	0.00025	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—LEP—psoriasis	1.89e-05	0.000249	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—APOE—psoriasis	1.89e-05	0.000249	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—NFKBIA—psoriasis	1.89e-05	0.000249	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—LEP—psoriasis	1.86e-05	0.000245	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—APOE—psoriasis	1.86e-05	0.000245	CbGpPWpGaD
Lisuride—ADRA2A—Hemostasis—TP53—psoriasis	1.85e-05	0.000243	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—VEGFA—psoriasis	1.85e-05	0.000243	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—TYK2—psoriasis	1.84e-05	0.000242	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—APOE—psoriasis	1.84e-05	0.000242	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—STAT3—psoriasis	1.83e-05	0.000241	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—NFKBIA—psoriasis	1.82e-05	0.00024	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—NFKBIA—psoriasis	1.82e-05	0.000239	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—NFKBIA—psoriasis	1.77e-05	0.000232	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—CXCL8—psoriasis	1.74e-05	0.000229	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—TYK2—psoriasis	1.74e-05	0.000229	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—NFKBIA—psoriasis	1.74e-05	0.000228	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—CXCL8—psoriasis	1.73e-05	0.000228	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—LEP—psoriasis	1.72e-05	0.000226	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—APOE—psoriasis	1.72e-05	0.000226	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—TYK2—psoriasis	1.71e-05	0.000225	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—TYK2—psoriasis	1.71e-05	0.000225	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—CXCL8—psoriasis	1.71e-05	0.000225	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—LEP—psoriasis	1.69e-05	0.000222	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—APOE—psoriasis	1.69e-05	0.000222	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—CXCL8—psoriasis	1.68e-05	0.000221	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—IL6—psoriasis	1.66e-05	0.000218	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CARM1—psoriasis	1.64e-05	0.000216	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—IL6—psoriasis	1.62e-05	0.000214	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—JUN—psoriasis	1.62e-05	0.000213	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CXCL8—psoriasis	1.6e-05	0.000211	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—PPARG—psoriasis	1.6e-05	0.000211	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—NFKBIA—psoriasis	1.6e-05	0.000211	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—IL6—psoriasis	1.6e-05	0.00021	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—JUN—psoriasis	1.59e-05	0.000209	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—NFKBIA—psoriasis	1.58e-05	0.000207	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—JUN—psoriasis	1.56e-05	0.000205	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—TYK2—psoriasis	1.56e-05	0.000205	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—NFKB1—psoriasis	1.56e-05	0.000205	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—TYK2—psoriasis	1.55e-05	0.000204	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—CAT—psoriasis	1.54e-05	0.000203	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—APOE—psoriasis	1.54e-05	0.000202	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—LEP—psoriasis	1.54e-05	0.000202	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—NFKB1—psoriasis	1.53e-05	0.000201	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—IL6—psoriasis	1.53e-05	0.000201	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CXCL8—psoriasis	1.51e-05	0.000199	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—NFKB1—psoriasis	1.5e-05	0.000198	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—TYK2—psoriasis	1.49e-05	0.000197	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CXCL8—psoriasis	1.49e-05	0.000196	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CXCL8—psoriasis	1.49e-05	0.000196	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—JUN—psoriasis	1.49e-05	0.000196	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—TYK2—psoriasis	1.49e-05	0.000196	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—TYK2—psoriasis	1.45e-05	0.00019	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—IL6—psoriasis	1.44e-05	0.000189	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—NFKB1—psoriasis	1.44e-05	0.000189	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—NFKBIA—psoriasis	1.43e-05	0.000189	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—TYK2—psoriasis	1.42e-05	0.000187	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—IL6—psoriasis	1.42e-05	0.000187	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—IL6—psoriasis	1.42e-05	0.000187	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—VEGFA—psoriasis	1.42e-05	0.000186	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—JUN—psoriasis	1.41e-05	0.000185	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—STAT3—psoriasis	1.4e-05	0.000184	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—TP53—psoriasis	1.4e-05	0.000184	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—JUN—psoriasis	1.39e-05	0.000183	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—JUN—psoriasis	1.39e-05	0.000183	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—VEGFA—psoriasis	1.39e-05	0.000182	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—STAT3—psoriasis	1.37e-05	0.000181	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—VEGFA—psoriasis	1.37e-05	0.00018	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CXCL8—psoriasis	1.36e-05	0.000179	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—NFKB1—psoriasis	1.35e-05	0.000178	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—STAT3—psoriasis	1.35e-05	0.000178	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CXCL8—psoriasis	1.35e-05	0.000177	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—NFKB1—psoriasis	1.34e-05	0.000176	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—NFKB1—psoriasis	1.34e-05	0.000176	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—TYK2—psoriasis	1.31e-05	0.000173	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—VEGFA—psoriasis	1.3e-05	0.000171	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CXCL8—psoriasis	1.3e-05	0.000171	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CXCL8—psoriasis	1.29e-05	0.00017	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—IL6—psoriasis	1.29e-05	0.00017	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—TYK2—psoriasis	1.29e-05	0.00017	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—STAT3—psoriasis	1.29e-05	0.00017	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—IL6—psoriasis	1.28e-05	0.000169	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—IL6—psoriasis	1.28e-05	0.000168	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—JUN—psoriasis	1.26e-05	0.000166	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CXCL8—psoriasis	1.26e-05	0.000166	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—JUN—psoriasis	1.25e-05	0.000165	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CXCL8—psoriasis	1.24e-05	0.000163	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—IL6—psoriasis	1.24e-05	0.000163	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—IL6—psoriasis	1.23e-05	0.000162	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—VEGFA—psoriasis	1.23e-05	0.000162	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—NFKB1—psoriasis	1.22e-05	0.00016	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—STAT3—psoriasis	1.22e-05	0.00016	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—VEGFA—psoriasis	1.21e-05	0.000159	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—VEGFA—psoriasis	1.21e-05	0.000159	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—JUN—psoriasis	1.21e-05	0.000159	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—NFKB1—psoriasis	1.21e-05	0.000159	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—JUN—psoriasis	1.2e-05	0.000158	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—STAT3—psoriasis	1.2e-05	0.000158	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—STAT3—psoriasis	1.2e-05	0.000158	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—APOE—psoriasis	1.2e-05	0.000158	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—IL6—psoriasis	1.2e-05	0.000157	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—IL6—psoriasis	1.18e-05	0.000155	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—TYK2—psoriasis	1.17e-05	0.000154	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—JUN—psoriasis	1.17e-05	0.000154	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—NFKB1—psoriasis	1.16e-05	0.000153	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—NFKB1—psoriasis	1.16e-05	0.000152	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—JUN—psoriasis	1.15e-05	0.000151	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CXCL8—psoriasis	1.14e-05	0.00015	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—NFKB1—psoriasis	1.13e-05	0.000148	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CXCL8—psoriasis	1.12e-05	0.000148	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—NFKB1—psoriasis	1.11e-05	0.000146	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—VEGFA—psoriasis	1.1e-05	0.000145	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—VEGFA—psoriasis	1.09e-05	0.000144	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—STAT3—psoriasis	1.09e-05	0.000144	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—IL6—psoriasis	1.09e-05	0.000143	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—STAT3—psoriasis	1.08e-05	0.000143	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—TP53—psoriasis	1.07e-05	0.000141	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—IL6—psoriasis	1.07e-05	0.000141	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—JUN—psoriasis	1.06e-05	0.00014	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—VEGFA—psoriasis	1.06e-05	0.000139	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—VEGFA—psoriasis	1.05e-05	0.000138	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—TP53—psoriasis	1.05e-05	0.000138	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—STAT3—psoriasis	1.05e-05	0.000138	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—JUN—psoriasis	1.05e-05	0.000137	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PPARG—psoriasis	1.04e-05	0.000137	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—STAT3—psoriasis	1.04e-05	0.000137	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—TP53—psoriasis	1.03e-05	0.000136	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CXCL8—psoriasis	1.02e-05	0.000134	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—VEGFA—psoriasis	1.02e-05	0.000134	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—NFKB1—psoriasis	1.02e-05	0.000134	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—STAT3—psoriasis	1.01e-05	0.000133	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CAT—psoriasis	1.01e-05	0.000133	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—VEGFA—psoriasis	1.01e-05	0.000132	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—NFKB1—psoriasis	1.01e-05	0.000132	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—STAT3—psoriasis	9.97e-06	0.000131	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—TP53—psoriasis	9.85e-06	0.000129	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—IL6—psoriasis	9.8e-06	0.000129	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—IL6—psoriasis	9.73e-06	0.000128	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—IL6—psoriasis	9.6e-06	0.000126	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—JUN—psoriasis	9.51e-06	0.000125	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—IL6—psoriasis	9.44e-06	0.000124	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—TP53—psoriasis	9.29e-06	0.000122	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—VEGFA—psoriasis	9.28e-06	0.000122	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—STAT3—psoriasis	9.19e-06	0.000121	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—TP53—psoriasis	9.16e-06	0.00012	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—TP53—psoriasis	9.16e-06	0.00012	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—NFKB1—psoriasis	9.15e-06	0.00012	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—VEGFA—psoriasis	9.13e-06	0.00012	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—STAT3—psoriasis	9.04e-06	0.000119	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—IL6—psoriasis	9.01e-06	0.000119	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—IL6—psoriasis	8.5e-06	0.000112	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—IL6—psoriasis	8.39e-06	0.00011	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—IL6—psoriasis	8.39e-06	0.00011	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—TP53—psoriasis	8.35e-06	0.00011	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—VEGFA—psoriasis	8.31e-06	0.000109	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—TP53—psoriasis	8.27e-06	0.000109	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—STAT3—psoriasis	8.23e-06	0.000108	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—TP53—psoriasis	7.99e-06	0.000105	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—TP53—psoriasis	7.94e-06	0.000104	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—APOE—psoriasis	7.84e-06	0.000103	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—TP53—psoriasis	7.73e-06	0.000102	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IL6—psoriasis	7.64e-06	0.0001	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—TP53—psoriasis	7.61e-06	0.0001	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IL6—psoriasis	7.57e-06	9.96e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IL6—psoriasis	7.31e-06	9.61e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IL6—psoriasis	7.27e-06	9.56e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IL6—psoriasis	7.07e-06	9.3e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—TP53—psoriasis	7.01e-06	9.22e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IL6—psoriasis	6.96e-06	9.15e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—TP53—psoriasis	6.9e-06	9.07e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PPARG—psoriasis	6.83e-06	8.98e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IL6—psoriasis	6.42e-06	8.44e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IL6—psoriasis	6.32e-06	8.3e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—TP53—psoriasis	6.28e-06	8.25e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IL6—psoriasis	5.75e-06	7.55e-05	CbGpPWpGaD
